Back

Medscape, LLC

  • Biosimilar Pharmaceuticals

The Impact of Biosimilar Products for People Living With Diabetes

The goal of this activity is for learners to be better able to adopt biosimilars through identifying patients with diabetes for whom these agents would be an appropriate treatment option and to enhance confidence in their use.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

IPCE CreditsUp to 0.5 creditsAMA PRA Category 1 Credit™Up to 0.5 creditsNursingUp to 0.5 creditsPharmacyUp to 0.5 credits

MOC types

ABIM — Medical KnowledgeUp to 0.5 points

FDA REMS

No

Qualifies for MIPS

No

Pricing

Free

Reported to ACCME by the provider

  • Enduring / On-demand
  • Credit · Up to 0.5 credits
  • MOC · Up to 0.5 points
  • Released
    Oct 4, 2024
  • Last day to claim credit
    Dec 4, 2026 7 weeks left